CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
HighwayRx   Banner2   Banner4   Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Restricting fructose intake may reduce kids' liver fat accumulation
03-19-2015
Charity attacks Gilead over hepatitis C drug restrictions
03-18-2015
New market for liver disease spawns race for better testing
03-18-2015
Steroids for Graves' eye disease may boost risk of statin hepatotoxicity
03-18-2015
View Complete News Library
 
 
May 2-6
AMERICAN TRANSPLANT CONGRESS
Philadelphia, Pennsylvania
May 6-9
48th ANNUAL MEETING- THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION (ESPGHAN)
Amsterdam, Netherlands
May 16-19
DDW 2015
Washington, DC
July 8-11
21ST ANNUAL INTERNATIONAL CONGRESS OF THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY (ILTS)
CHICAGO, IL
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013
 
Grazoprevir/Elbasvir plus Ribavirin For Chronic HCV Genotype-1 Infection After Failure of Combination Therapy Containing a Direct-Acting Antiviral Agent
 
Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-?-induced protein 10 levels in HBV/HCV-coinfected patients
 
Hepatitis C virus reinfection and spontaneous clearance of reinfection - the InC3 study
 
Treatment of hepatitis C in difficult-to-treat patients
 
Ledipasvir/Sofosbuvir: A Review of Its Use in Chronic Hepatitis C
 
 
Outcomes of Infants Born to Women Infected With Hepatitis B
 
The Epidemiology of Acute Hepatitis B in the United States from Population-Based Surveillance, 2006-2011
 
Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening
 
Intended and unintended effects of large-scale adverse event disclosure: a controlled before-after analysis of five large-scale notifications
 
Impact of Physician Specialty on Quality Care for Patients Hospitalized with Decompensated Cirrhosis
 
Management of patients with decompensated cirrhosis
 
 
Salivary Microbiota Reflects Changes in Gut Microbiota in Cirrhosis with Hepatic Encephalopathy
 
Psychoactive Medications Increase the Risk of Falls and Fall-Related Injuries in Hospitalized Patients with Cirrhosis
 
Tivozanib: status of development
 
The Race to Liver Transplantation: A Comparison of Patients With and Without Hepatocellular Carcinoma from Listing to Post-Transplantation
 
Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
 
Associations between Pre-S Deletion Mutation of Hepatitis B Virus and Risk of Hepatocellular Carcinoma in the Asian Population: A Meta-Analysis
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.